US FDA Disapproves Anti-Seizure Drug ‘Lamotrigine’ of Eton Pharmaceuticals
On Friday, 27th May 2022, Eton Pharmaceuticals Inc. said, the Food and Drug Administration (FDA) of the United States has declined to approve the company’s anti-seizure drug known as lamotrigine, which has sent the shares of the company down by 13 percent in the extended trading. The company had been notified that, its privately held […]
Continue Reading